Technological advancements in the production of viral vectors, cell processing, and quality assurance are further contributing to market expansion. Furthermore, supportive regulatory frameworks and the introduction of more cell and gene therapies into the market are enhancing the industry's overall outlook, indicating a promising future for this sector.